Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Resistant Bacterial Infection”

219 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 219 results

Testing effectiveness (Phase 2)Ended earlyNCT05971602
What this trial is testing

Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Gates Medical Research Institute 93
Post-approval studies (Phase 4)Active Not RecruitingNCT03335072
What this trial is testing

Kebele Elimination of Trachoma for Ocular Health

Who this might be right for
Trachoma
University of California, San Francisco 320,000
Not applicableEnded earlyNCT01381757
What this trial is testing

Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali

Who this might be right for
Tuberculosis, PulmonaryMycobacterium TuberculousAntitubercular Agents+3 more
National Institute of Allergy and Infectious Diseases (NIAID) 34
Testing effectiveness (Phase 2)Study completedNCT04179500
What this trial is testing

A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+2 more
Global Alliance for TB Drug Development 26
Not applicableStudy completedNCT04383106
What this trial is testing

Bowel Colonization With Multi-drug Resistant Bacterial Species in Hospitalized Patients With acute-on Chronic Liver Failure (ACLF), and Its Relationship With Extra-intestinal Infectious Events and Short-term Outcomes.

Who this might be right for
Acute-On-Chronic Liver Failure
Institute of Liver and Biliary Sciences, India 150
Large-scale testing (Phase 3)UnknownNCT02120638
What this trial is testing

Optimization of MDR-TB Treatment Regimen Based on the Molecular Drug Susceptibility Results of Pyrazinamide

Who this might be right for
Multidrug Resistant Tuberculosis
Huashan Hospital 100
Post-approval studies (Phase 4)Study completedNCT02231229
What this trial is testing

Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation

Who this might be right for
Tuberculosis
Assistance Publique - Hôpitaux de Paris 204
Early research (Phase 1)Study completedNCT03910673
What this trial is testing

Intravenous Fosfomycin Pharmacokinetics Study

Who this might be right for
Bacterial InfectionMultiple-drug ResistancePathogen Resistance
National Institute of Allergy and Infectious Diseases (NIAID) 39
Not applicableNot Yet RecruitingNCT06674291
What this trial is testing

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Who this might be right for
Tuberculosis, Multidrug-Resistant
Korea Otsuka Pharmaceutical Co., Ltd. 222
Not applicableStudy completedNCT07013864
What this trial is testing

Staphylococcus Haemolyticus in the Neonatal Intensive Care Unit of CHSD in 2023: Analysis and Trends

Who this might be right for
Staphylococcus HaemolyticusStaphylococcal InfectionsSepsis+5 more
Centre Hospitalier de Saint-Denis 28
Not applicableStudy completedNCT06760143
What this trial is testing

Antibiotic Prophylaxis in Lung-Transplant Recipients

Who this might be right for
Lung-transplant RecipientsAntibiotic Prophylaxis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 90
Early research (Phase 1)Study completedNCT01856634
What this trial is testing

Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis

Who this might be right for
Multidrug Resistant TuberculosisPediatric
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Testing effectiveness (Phase 2)Looking for participantsNCT04759001
What this trial is testing

FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae

Who this might be right for
Enterobacteriaceae InfectionsMulti-antibiotic Resistance
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 52
Not applicableLooking for participantsNCT06738771
What this trial is testing

Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa

Who this might be right for
Pseudomonas InfectionsPseudomonas AeruginosaPrognosis+3 more
Centre Hospitalier Régional d'Orléans 600
Not applicableStudy completedNCT02729532
What this trial is testing

Effect of Xpert MTB/RIF on Patient Outcomes

Who this might be right for
Tuberculosis
University of North Carolina, Chapel Hill 776
Post-approval studies (Phase 4)Study completedNCT03830671
What this trial is testing

The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB

Who this might be right for
Multi-drug Resistant Tuberculosis
Beijing Chest Hospital 515
Large-scale testing (Phase 3)Not Yet RecruitingNCT07268664
What this trial is testing

Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese Cohort

Who this might be right for
Rifampicin Resistant TuberculosisPulmonary TuberculosisTuberculosis+1 more
Beijing Chest Hospital 120
Testing effectiveness (Phase 2)Study completedNCT00664313
What this trial is testing

TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB

Who this might be right for
Multi-drug Resistant TuberculosisExtensively Drug Resistant Tuberculosis
Centers for Disease Control and Prevention 36
Not applicableStudy completedNCT04812847
What this trial is testing

Multidrug Resistant Gram-negative Pathogen Infections in High Risk Neonates in the Northeast of Mexico

Who this might be right for
Infant Newborn Disease
Instituto Tecnologico y de Estudios Superiores de Monterey 597
Not applicableActive Not RecruitingNCT04567368
What this trial is testing

TB-CAPT MTB/XDR Study

Who this might be right for
TuberculosisResistance BacterialDiagnoses Disease
Foundation for Innovative New Diagnostics, Switzerland 753
Load More Results